2023
DOI: 10.3390/dermatopathology10030035
|View full text |Cite
|
Sign up to set email alerts
|

Endocrine Mucin-Producing Sweat Gland Carcinoma: Case Presentation with a Comprehensive Review of the Literature

Gerardo Cazzato,
Emilio Bellitti,
Irma Trilli
et al.

Abstract: (1) Background: Endocrine Mucin-Producing Sweat Gland Carcinoma (EMPSGC) is a rare, low-grade, neuroendocrine-differentiated, cutaneous adnexal tumor, officially recognized by the World Health Organization (WHO) Skin Tumors Classification in 2018 as a separate entity and homologue of endocrine ductal carcinoma in situ (eDCIS)/solid papillary carcinoma of the breast. Although it is more frequent in the female sex, between 60 and 70 years old, in the peri-orbital region, EMPSGC has also been described in the mal… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 62 publications
0
7
0
Order By: Relevance
“…Endocrine mucin-producing sweat gland carcinoma was previously believed to be a low-grade neuroendocrine neoplasm with an indolent clinical course and a low rate of recurrence (<10%) following excision [2,3,5,12]. There have now been seven reported cases since 2020 of metastases, including this case, with the majority metastasizing to the parotid gland and none metastasizing to the lungs [3,7,8].…”
Section: Discussionmentioning
confidence: 78%
See 4 more Smart Citations
“…Endocrine mucin-producing sweat gland carcinoma was previously believed to be a low-grade neuroendocrine neoplasm with an indolent clinical course and a low rate of recurrence (<10%) following excision [2,3,5,12]. There have now been seven reported cases since 2020 of metastases, including this case, with the majority metastasizing to the parotid gland and none metastasizing to the lungs [3,7,8].…”
Section: Discussionmentioning
confidence: 78%
“…It is important to differentiate this lesion from mucinous carcinoma and breast solid papillary carcinoma with neuroendocrine differentiation (SPCND). Mucinous carcinoma is differentiated due to its small clusters of cells with cribriform or tubular structures in large pools of extracellular mucin, whereas metastatic SPCND shows similar features and an immunohistochemical profile [2,3,13]. Although classically thought of as having more than 90% extracellular mucin, neuroendocrine and non-neuroendocrine mucinous carcinoma is now well known to exist in either pure form (>90%) or in a mixed pattern, which can lead to diagnostic confusion if the mucinous component is not properly sampled, as its presence, even in mixed form, should classify the lesion as a mucinous carcinoma [12,14,15].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations